Enzon Pharmaceuticals Inc.’s(ENZN) MACD indicator has moved into bearish territory with a reading of -0.0092. The Zacks #5 Rank (“Strong Sell”) stock has slipped more than 1% to $7.87 in morning trade. The full-year Zacks Consensus Estimate is currently pegged at a loss of 24 cents per share, which has worsened by 6 cents over the past month.
“ENZN” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research